Animalcare Group (ANCR) Competitors GBX 249.50 +0.50 (+0.20%) As of 09/12/2025 12:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock ANCR vs. AMYT, AGY, APH, BXP, STX, VLG, EAH, DNL, PXS, and MXCShould you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), Shield Therapeutics (STX), Venture Life Group (VLG), ECO Animal Health Group (EAH), Diurnal Group (DNL), Provexis (PXS), and Argent BioPharma (MXC). These companies are all part of the "drug manufacturers - specialty & generic" industry. Animalcare Group vs. Its Competitors Amryt Pharma Allergy Therapeutics Alliance Pharma Beximco Pharmaceuticals Shield Therapeutics Venture Life Group ECO Animal Health Group Diurnal Group Provexis Argent BioPharma Amryt Pharma (LON:AMYT) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability. Is AMYT or ANCR more profitable? Animalcare Group has a net margin of 43.05% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 36.62% beat Amryt Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Amryt PharmaN/A N/A N/A Animalcare Group 43.05%36.62%2.97% Do insiders & institutionals believe in AMYT or ANCR? 23.1% of Animalcare Group shares are held by institutional investors. 30.2% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, AMYT or ANCR? Animalcare Group has lower revenue, but higher earnings than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmryt Pharma£210.24M0.00N/A-£33.00N/AAnimalcare Group£74.23M2.32£36.55M£0.30834.45 Does the media refer more to AMYT or ANCR? In the previous week, Animalcare Group had 2 more articles in the media than Amryt Pharma. MarketBeat recorded 2 mentions for Animalcare Group and 0 mentions for Amryt Pharma. Animalcare Group's average media sentiment score of 0.37 beat Amryt Pharma's score of 0.00 indicating that Animalcare Group is being referred to more favorably in the news media. Company Overall Sentiment Amryt Pharma Neutral Animalcare Group Neutral SummaryAnimalcare Group beats Amryt Pharma on 9 of the 10 factors compared between the two stocks. Get Animalcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANCR vs. The Competition Export to ExcelMetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£172.13M£1.67B£5.87B£2.58BDividend Yield1.98%2.93%5.68%5.30%P/E Ratio834.4565.3974.525,410.64Price / Sales2.321,297.60549.7896,691.09Price / Cash26.0510.3737.5627.93Price / Book1.5411.9112.167.76Net Income£36.55M£20.70B£3.28B£5.89B7 Day Performance-1.77%0.71%0.87%6.47%1 Month Performance-5.64%1.70%4.96%55.91%1 Year Performance2.25%4.77%60.74%147.81% Animalcare Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANCRAnimalcare GroupN/AGBX 249.50+0.2%N/A+4.0%£172.13M£74.23M834.45220News CoverageAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 7.50-11.8%N/A+93.0%£357.48M£55.66M-1,041.67612APHAlliance Pharma1.8945 of 5 starsGBX 64.70flatGBX 6,250+9,560.0%N/A£350.32M£183.50M-10.4391,000BXPBeximco PharmaceuticalsN/AGBX 45.62-1.9%N/A+111.5%£203.52M£46.34B3.205,500News CoverageGap UpSTXShield TherapeuticsN/AGBX 7.89-3.8%N/A+116.9%£82.18M£41.50M-394.4540,000Gap UpHigh Trading VolumeVLGVenture Life GroupN/AGBX 59.92+0.7%N/A+24.3%£76.73M£26.59M-23,967.20165News CoverageEAHECO Animal Health GroupN/AGBX 73-0.7%GBX 150+105.5%-32.3%£49.47M£79.60M3,004.12234DNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133PXSProvexisN/AGBX 0.78+6.1%N/A-7.2%£18.30M£1.20M-2,600.004News CoverageGap UpMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up Related Companies and Tools Related Companies Amryt Pharma Alternatives Allergy Therapeutics Alternatives Alliance Pharma Alternatives Beximco Pharmaceuticals Alternatives Shield Therapeutics Alternatives Venture Life Group Alternatives ECO Animal Health Group Alternatives Diurnal Group Alternatives Provexis Alternatives Argent BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ANCR) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Animalcare Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Animalcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANCR Stock Alerts